FGF23 and chronic kidney disease: CKD represents another systemic amplifier of PH-HFpEF, with elevated levels of fibroblast growth factor-23 (FGF-23), oxidative stress, and vascular calcification contributing to endothelial dysfunction and increased PVR [28,29].